DrugPatentWatch Database Preview
PANTOPRAZOLE SODIUM Drug Profile
» See Plans and Pricing
Which patents cover Pantoprazole Sodium, and when can generic versions of Pantoprazole Sodium launch?
Pantoprazole Sodium is a drug marketed by Sun Pharm, Akorn Inc, Aurobindo Pharma Ltd, Mylan Labs Ltd, Sandoz Inc, Hikma, Actavis Totowa, Amneal Pharms, Atlantide, Dr Reddys Labs Ltd, Hetero Labs Ltd V, Ingenus Pharms Llc, Jubilant Generics, L Perrigo Co, Lannett Co Inc, Macleods Pharms Ltd, Mylan Pharms Inc, Orchid Hlthcare, Rubicon, Sun Pharm Inds Ltd, Teva, and Torrent Pharms. and is included in twenty-five NDAs.
The generic ingredient in PANTOPRAZOLE SODIUM is pantoprazole sodium. There are forty-eight drug master file entries for this compound. Fifty-one suppliers are listed for this compound. Additional details are available on the pantoprazole sodium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Pantoprazole Sodium
A generic version of PANTOPRAZOLE SODIUM was approved as pantoprazole sodium by ATLANTIDE on January 19th, 2011.
Summary for PANTOPRAZOLE SODIUM
US Patents: | 0 |
Applicants: | 22 |
NDAs: | 25 |
Finished Product Suppliers / Packagers: | 50 |
Raw Ingredient (Bulk) Api Vendors: | 55 |
Clinical Trials: | 22 |
Patent Applications: | 3,165 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for PANTOPRAZOLE SODIUM |
Drug Sales Revenues: | Drug sales revenues for PANTOPRAZOLE SODIUM |
What excipients (inactive ingredients) are in PANTOPRAZOLE SODIUM? | PANTOPRAZOLE SODIUM excipients list |
DailyMed Link: | PANTOPRAZOLE SODIUM at DailyMed |


See drug prices for PANTOPRAZOLE SODIUM

Recent Clinical Trials for PANTOPRAZOLE SODIUM
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Mansoura University | N/A |
Fundação de Amparo à Pesquisa do Estado de São Paulo | Phase 4 |
Federal University of São Paulo | Phase 4 |
Pharmacology for PANTOPRAZOLE SODIUM
Drug Class | Proton Pump Inhibitor |
Mechanism of Action | Proton Pump Inhibitors |
Paragraph IV (Patent) Challenges for PANTOPRAZOLE SODIUM
Tradename | Dosage | Ingredient | NDA | Submissiondate |
---|---|---|---|---|
PROTONIX IV | INJECTABLE;IV (INFUSION) | pantoprazole sodium | 020988 | 2005-04-07 |
PROTONIX | TABLET, DELAYED RELEASE;ORAL | pantoprazole sodium | 020987 | 2004-02-02 |
PROTONIX | FOR SUSPENSION, DELAYED RELEASE;ORAL | pantoprazole sodium | 022020 |
US Patents and Regulatory Information for PANTOPRAZOLE SODIUM
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Torrent Pharms | PANTOPRAZOLE SODIUM | pantoprazole sodium | TABLET, DELAYED RELEASE;ORAL | 090074-002 | Jan 19, 2011 | AB | RX | No | No | Get Started Free | Get Started Free | Get Started Free | |||
Rubicon | PANTOPRAZOLE SODIUM | pantoprazole sodium | TABLET, DELAYED RELEASE;ORAL | 090807-001 | May 2, 2012 | AB | RX | No | No | Get Started Free | Get Started Free | Get Started Free | |||
Mylan Pharms Inc | PANTOPRAZOLE SODIUM | pantoprazole sodium | TABLET, DELAYED RELEASE;ORAL | 090970-001 | Jan 19, 2011 | AB | RX | No | No | Get Started Free | Get Started Free | Get Started Free | |||
Rubicon | PANTOPRAZOLE SODIUM | pantoprazole sodium | TABLET, DELAYED RELEASE;ORAL | 090807-002 | May 2, 2012 | AB | RX | No | No | Get Started Free | Get Started Free | Get Started Free | |||
Mylan Pharms Inc | PANTOPRAZOLE SODIUM | pantoprazole sodium | TABLET, DELAYED RELEASE;ORAL | 090970-002 | Jan 19, 2011 | AB | RX | No | No | Get Started Free | Get Started Free | Get Started Free | |||
Sun Pharm | PANTOPRAZOLE SODIUM | pantoprazole sodium | FOR SUSPENSION, DELAYED RELEASE;ORAL | 213725-001 | Jun 30, 2020 | AB | RX | No | No | Get Started Free | Get Started Free | Get Started Free | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |